CN1166367C - Medicine for external application for curing psoriasis - Google Patents

Medicine for external application for curing psoriasis Download PDF

Info

Publication number
CN1166367C
CN1166367C CNB011282800A CN01128280A CN1166367C CN 1166367 C CN1166367 C CN 1166367C CN B011282800 A CNB011282800 A CN B011282800A CN 01128280 A CN01128280 A CN 01128280A CN 1166367 C CN1166367 C CN 1166367C
Authority
CN
China
Prior art keywords
medicine
psoriasis
external application
paste
calomelas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011282800A
Other languages
Chinese (zh)
Other versions
CN1411817A (en
Inventor
朱辉章
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011282800A priority Critical patent/CN1166367C/en
Publication of CN1411817A publication Critical patent/CN1411817A/en
Application granted granted Critical
Publication of CN1166367C publication Critical patent/CN1166367C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to externally applied medicine for treating psoriasis, which comprises the components by weight: 3 to 10 g of white downborne elixir, 5 to 15 g of calomelas and 3 to 10 portions of hydrargyri oxydum rubrum, and the components are prepared into fine powder to be regulated into externally applied paste with vaseline oil. The paste has the advantages of simple preparation method and low cost and has special effect on psoriasis. By three-year trial, the total effective rate can reach over 95%, and the medicine has certain curative effect on dermatosis such as eczema, flat warts, etc.

Description

The psoriasic medicine for external use of a kind of treatment
Technical field: the present invention relates to a kind of medicine, the psoriasic medicine for external use of promptly a kind of treatment.
Background technology: psoriasis, modern medicine claim " psoriasis ", and when just sending out, the erythema pimple appears in patient skin, and rapid then expanded scope forms coin or map shape, covers squama, the visible thin film of scaling, and visible blood point under the thin film claims psoriasis vulgaris.If skin has pustule, and regular outbreak, psoriasis pustulosa be called.Soak into if skin is diffuse erythema, then be called erythrodermic psoriasis with a large amount of desquamations.At present, a lot of about the antipsoriatic method of rash, but how undesirable curative effect is, what have also needs higher expense and condition.Thereby in pastoral area, vast rural area, this disease is still tormenting many patients.
Summary of the invention: the present invention is directed to the problems referred to above, adopt Chinese herbal medicine to develop topical agent, its weight portion prescription is: Hydrargyrum chloratum Compositum 3-10 part, and Calomelas 5-15 part, Hydrargyri Oxydum Rubrum 3-10 part, Realgar 5-10 part is all got fine powder vaseline oil furnishing external application paste.This ointment method for making is simple, with low cost, and psoriasis is had specially good effect, and through nearly 3 years trying out, total effective rate can reach more than 95%.Dermatosiss such as eczema, verruca plana also there is certain curative effect.
Embodiment: Hydrargyrum chloratum Compositum, Calomelas, Hydrargyri Oxydum Rubrum, the Realgar of weight such as get, porphyrize mixes, with vaseline oil furnishing paste.
Usage: affected part coating skim, twice on the one.
Note not inlet eye, avoid and drink, avoid the pungent stimulating food of ichthyophagy.Warm calm place is suitable in medicine-feeding.If medicine-feeding place pain, in addition red and swollen, should reduce dose.Hydrargyrum allergy sufferers forbidding.
Pharmacodynamic analysis: Hydrargyrum chloratum Compositum belongs to the mixed crystallization of mercuric chloride and calomel, and severe toxicity and intensive corrosivity are arranged, and the effect of eliminating pus and toxicity is also arranged.Calomelas is the mercury compound that hydrargyrum, Alumen, Sal etc. are made with sublimed method, has the skin ulcer of holding back parasite killing, the effect of the relieving constipation of relieving oedema or abdominal distension through diuresis or purgation.Hydrargyri Oxydum Rubrum is the mercuride that hydrargyrum, Alumen, Borax are made into, and is close with the Calomelas drug effect, and the stronger osmosis of adhering to is arranged.Realgar is arsenical crystallization Ore, and often the form with red arsenic sulfide exists.Hydrargyrum chloratum Compositum toxicity is stronger, and is unsuitable oral.Though several toxicity in back are strong, relax, traditional Chinese medical science low dose commonly used is gone into ball and is loose for oral administration.Above-mentioned medicine is mixed, and strong toxicity is slow to differ, and the efficacy of a drug is lasting, and permeability is strong, than single use curative effect multiplication.
Modern medicine is a lot of to psoriatic cause of disease saying, mainly contains " heredity ", " virus ", " bacterial infection ", " Nervous and Mental Factors ", " endocrine factors ", " wound initiation ", " dysbolismus ", " immunocompromised " etc.This medicine is primarily aimed at the causes of disease such as biological virus and antibacterial.Because medicament is the arsenic mercurial, toxicity is stronger, and virus, antibacterial are had kill activity, skilfully use the corrosiveness of medicine in addition, obtain permeability preferably, take into account the violence and the persistency of drug effect, can't survival environment thereby made viral pathogenic bacteria, receive the effect for the treatment of the poisonous disease with poisonous drugs.
The clinical experiment situation:
1, diagnoses and treatment standard: the diagnosis and the treatment standard that adopt each opinion the 32 chapter of always touching upon in " modern dermatological " (publishing house of Shanghai Medical Univ publishes, Yang Guoliang, Wang Xiasheng chief editor) to be proposed.
2, experimental data: clinical treatment 44 examples, wherein cure 35 examples, account for 79.5%.Recur once in 2 years, through medication skin lesion disappearance person 3 people, 6.8%.Remission, but dissatisfied person 4 people of curative effect account for 9%.Ineffective person 2 people account for 4.5%, total effective rate 95.5%.

Claims (1)

1, the psoriasic medicine for external use of a kind of treatment is characterized in that: prescription by weight, and Hydrargyrum chloratum Compositum 3-10 part, Calomelas 5-15 part, Hydrargyri Oxydum Rubrum 3-10 part, Realgar 5-10 part is all got fine powder with vaseline oil furnishing external application paste.
CNB011282800A 2001-10-11 2001-10-11 Medicine for external application for curing psoriasis Expired - Fee Related CN1166367C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011282800A CN1166367C (en) 2001-10-11 2001-10-11 Medicine for external application for curing psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011282800A CN1166367C (en) 2001-10-11 2001-10-11 Medicine for external application for curing psoriasis

Publications (2)

Publication Number Publication Date
CN1411817A CN1411817A (en) 2003-04-23
CN1166367C true CN1166367C (en) 2004-09-15

Family

ID=4668154

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011282800A Expired - Fee Related CN1166367C (en) 2001-10-11 2001-10-11 Medicine for external application for curing psoriasis

Country Status (1)

Country Link
CN (1) CN1166367C (en)

Also Published As

Publication number Publication date
CN1411817A (en) 2003-04-23

Similar Documents

Publication Publication Date Title
Merz et al. Fungating wounds–multidimensional challenge in palliative care
CN101757117A (en) Chinese herb medicine conditioner and preparation method thereof
CN1100945A (en) Broad spectrum detoxicating medicine for curing snakebite
CN110680870A (en) Pain-relieving itching-relieving swelling-diminishing detoxifying liquid and preparation method thereof
CN1166367C (en) Medicine for external application for curing psoriasis
RU2320329C1 (en) Method for complex therapy of average-degree oral phlegmons
CN1259098C (en) Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method
CN107596355A (en) A kind of Medical pain easing, the exterior-applied gel subsided a swelling, brought down a fever and preparation method thereof
CN1067879C (en) Preparation of medicament containing rare-earth for dermatomycosis
RU2284825C1 (en) Method for treating abscesses, soft tissue phlegmons
WO2006099789A1 (en) A pharmaceutical preparation
CN1093277A (en) Bee glue ointment for curing chilblain
CN103585330B (en) A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof
CN112569297A (en) External medicine for diabetic foot wound
CN1273161C (en) Ru'an oral liquor
CN1903214A (en) Ointment containing red precipitate
CN102266408A (en) Chinese medicine preparation for intervening in cutaneous prutitus and preparation method thereof
CN1989950A (en) Sterilizing effective antipruritic application agent
CN1079237C (en) Dog bone scald medicine
RU2196590C1 (en) Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses
Sircus Healing With Iodine: Your Missing Link To Better Health
RU2172634C2 (en) Bronchial asthma treatment method
CN101912398B (en) Medicament for treating urinary tract infection
CN1189183C (en) Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases
CN101129404A (en) External use medicine for treating psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee